窪田製薬ホールディングス(株)の貸借新規成約高詳細

主市場業種証券コード/EDINET英名称
東証GRT医薬品4596/ - -
公表日公表担保新規貸付前週比新規借入(自己)前週比新規借入(転貸)前週比
2024/12/06日証協無担保0株0%0株0%36,640株+40.38%
2024/12/06日証協有担保2,263,664株+41.72%0株0%72,100株+1.41%
2024/11/29日証協無担保0株0%0株0%26,100株-51.93%
2024/11/29日証協有担保1,597,232株+576.79%0株-100%71,100株-66.06%
2024/11/22日証協無担保0株0%0株-100%54,300株+193.51%
2024/11/22日証協有担保236,000株-19.59%11,600株+22.11%209,501株-18.68%
2024/11/15日証協無担保0株-100%400株+300%18,500株-68.38%
2024/11/15日証協有担保293,500株-62.21%9,500株+25%257,625株+197.49%
2024/11/08日証協無担保900株+800%100株0%58,500株+181.25%
2024/11/08日証協有担保776,732株-3.78%7,600株+1420%86,600株-56%
2024/11/01日証協無担保100株0%0株0%20,800株-49.91%
2024/11/01日証協有担保807,232株+452.52%500株-97.61%196,800株+22.85%
2024/10/25日証協無担保100株0%0株0%41,525株+400.3%
2024/10/25日証協有担保146,100株-49.74%20,900株+335.42%160,200株+389.91%
2024/10/18日証協無担保0株-100%0株0%8,300株-95.15%
2024/10/18日証協有担保290,700株-85.84%4,800株-46.67%32,700株-86.75%
2024/10/11日証協無担保700株0%0株0%171,050株+1017.97%
2024/10/11日証協有担保2,053,132株+107.14%9,000株-80.26%246,800株+50.76%
2024/10/04日証協無担保0株0%0株0%15,300株+27.5%
2024/10/04日証協有担保991,200株+240.03%45,600株+30.29%163,700株+7.91%
2024/09/27日証協無担保0株0%0株0%12,000株-67.3%
2024/09/27日証協有担保291,500株-78.95%35,000株0%151,700株-47.29%
2024/09/20日証協無担保0株-100%0株0%36,700株-64.54%
2024/09/20日証協有担保1,384,900株-73.29%0株-100%287,800株-15.58%
2024/09/13日証協無担保9,600株+231.03%0株0%103,500株+9.99%
2024/09/13日証協有担保5,184,500株+3.07%126,700株+310.03%340,900株+65.41%
2024/09/06日証協無担保2,900株0%0株0%94,100株+321.97%
2024/09/06日証協有担保5,029,900株+147.11%30,900株+466.35%206,100株+80.31%
2024/08/30日証協無担保0株0%0株0%22,300株-65.16%
2024/08/30日証協有担保2,035,500株+4.65%5,456株0%114,300株-52.12%
2024/08/23日証協無担保0株0%0株0%64,002株-25.06%
2024/08/23日証協有担保1,945,000株+80.11%0株-100%238,700株+38.7%
2024/08/16日証協無担保0株0%0株0%85,400株-68.52%
2024/08/16日証協有担保1,079,900株-81.55%26,500株0%172,100株-61.8%
2024/08/09日証協無担保0株-100%0株0%271,300株+55.56%
2024/08/09日証協有担保5,854,000株+40.94%0株-100%450,500株+83.88%
2024/08/02日証協無担保11,100株+326.92%0株-100%174,400株+158.37%
2024/08/02日証協有担保4,153,600株+209.16%54,200株-16.1%245,000株-37.48%

※株式分割は考慮していませんのでご注意ください。

Page Top